MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge
Abstract Rett syndrome is a severe and progressive neurological disorder linked to mutations in the MeCP2 gene. It has been suggested that immune alterations may play an active role in the generation and/or maintenance of RTT phenotypes. However, there is no clear consensus about which pathways are...
Saved in:
Main Authors: | M. I. Zalosnik, M. C. Fabio, M. L. Bertoldi, C. N. Castañares, A. L. Degano |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e167572fef6d48aba42e87b6f968b708 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
by: Derek J. C. Tai, et al.
Published: (2016) -
Sequence features accurately predict genome-wide MeCP2 binding in vivo
by: H. Tomas Rube, et al.
Published: (2016) -
Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment
by: Justin J. -L. Wong, et al.
Published: (2017) -
MeCP2 regulates gene expression through recognition of H3K27me3
by: Wooje Lee, et al.
Published: (2020) -
Rett syndrome linked to defects in forming the MeCP2/Rbfox/LASR complex in mouse models
by: Yan Jiang, et al.
Published: (2021)